Generation Bio (GBIO) Cash from Operations (2021 - 2025)
Historic Cash from Operations for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to -$52.7 million.
- Generation Bio's Cash from Operations fell 16950.43% to -$52.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.7 million, marking a year-over-year decrease of 1625.97%. This contributed to the annual value of -$88.6 million for FY2024, which is 6790.79% down from last year.
- Latest data reveals that Generation Bio reported Cash from Operations of -$52.7 million as of Q3 2025, which was down 16950.43% from -$16.8 million recorded in Q2 2025.
- In the past 5 years, Generation Bio's Cash from Operations registered a high of $24.8 million during Q2 2023, and its lowest value of -$52.7 million during Q3 2025.
- Over the past 5 years, Generation Bio's median Cash from Operations value was -$23.0 million (recorded in 2021), while the average stood at -$22.8 million.
- In the last 5 years, Generation Bio's Cash from Operations skyrocketed by 20540.94% in 2023 and then plummeted by 18681.37% in 2024.
- Quarter analysis of 5 years shows Generation Bio's Cash from Operations stood at -$20.8 million in 2021, then dropped by 10.58% to -$23.0 million in 2022, then fell by 8.59% to -$25.0 million in 2023, then skyrocketed by 36.81% to -$15.8 million in 2024, then crashed by 233.76% to -$52.7 million in 2025.
- Its last three reported values are -$52.7 million in Q3 2025, -$16.8 million for Q2 2025, and -$28.4 million during Q1 2025.